BBSE3:BMFBOVESPABB Seguridade Participacoes SA Analysis
Data as of 2026-03-14 - not real-time
R$35.05
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
BB Seguridade (BBSE3) trades at a trailing P/E of 7.5, well below the industry average of 16.3, and offers a dividend yield of 14.9% with a payout ratio near 92%. The company generates robust cash flow, posting free cash flow of roughly R$6.86 bn and carries no debt, underpinning the high dividend sustainability. With a return on equity of 90% and gross margins above 98%, the fundamentals are exceptionally strong, yet revenue growth remains modest at 0.2%. Technicals show a neutral price trend, the 20‑day SMA (~34.53) sits just below the current price (35.05) and the MACD histogram is positive, indicating a slight bullish bias despite decreasing volume. Volatility over the last 30 days is high at 39%, but the stock’s beta is very low (0.16), suggesting limited market‑wide risk. Recent news confirms a 5% YoY profit increase in Q4 2025 and a record dividend payout, reinforcing the income appeal. However, management signals a more conservative outlook for 2026, with premium growth expected to range between –3% and +2%, which could temper earnings momentum. The DCF‑derived fair value of R$53.6 implies a substantial long‑term upside, while analyst price targets average around R$37.5, indicating a modest near‑term upside of about 7.7%. In sum, BBSE3 combines deep value pricing, exceptional dividend yield, and a solid balance sheet, but faces near‑term earnings conservatism and elevated short‑term volatility.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 7/10
Key Factors
- High dividend yield and sustainable payout
- Undervalued relative to DCF fair value
- Technical bullish signal from MACD histogram
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Conservative earnings outlook for 2026
- Elevated short‑term volatility
- Strong cash generation supporting dividend
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant long‑term upside potential from DCF valuation
- Robust balance sheet with zero debt
- Consistently high ROE and cash flow supporting dividend growth
Key Metrics & Analysis
Financial Health
Revenue Growth0.20%
Profit Margin87.25%
P/E Ratio7.5
ROE89.81%
ROA27.60%
P/B Ratio6.6
Op. Cash FlowR$3.7B
Free Cash FlowR$6.9B
Industry P/E16.4
Technical Analysis
TrendNeutral
RSI50.1
SupportR$33.02
ResistanceR$39.30
MA 20R$34.53
MA 50R$35.69
MA 200R$34.44
MACDBullish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair ValueR$53.59
Target PriceR$37.75
Upside/Downside7.70%
GradeUndervalued
TypeValue
Dividend Yield14.87%
Risk Assessment
Beta0.16
Volatility38.99%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.